These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32008230)

  • 1. Regulatory Issues of Voluntary Certification of Food Supplements in Russia.
    Lozda R
    Ther Innov Regul Sci; 2020 Jan; 54(1):177-183. PubMed ID: 32008230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Strategy of Voluntary Certification in Italian Olive Oil Industry: Who and Why?
    Riganelli C; Marchini A
    Recent Pat Food Nutr Agric; 2016; 8(1):9-18. PubMed ID: 26957464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False and misleading health-related claims in food supplements on Spanish radio: an analysis from a European Regulatory Framework.
    Muela-Molina C; Perelló-Oliver S; García-Arranz A
    Public Health Nutr; 2021 Oct; 24(15):5156-5165. PubMed ID: 33972003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutrition labelling: perspectives of a bi-national agency for Australia and New Zealand.
    Curran MA
    Asia Pac J Clin Nutr; 2002; 11(2):S72-6. PubMed ID: 12074190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Marketability of food supplements - criteria for the legal assessment].
    Breitweg-Lehmann E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):277-285. PubMed ID: 28078356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-Related Content of TV and Radio Advertising of Dietary Supplements-Analysis of Legal Aspects after Introduction of Self-Regulation for Advertising of These Products in Poland.
    Wierzejska RE; Wiosetek-Reske A; Siuba-Strzelińska M; Wojda B
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential Features of Third-Party Certification Programs for Dietary Supplements: A Consensus Statement.
    Eichner AK; Coyles J; Fedoruk M; Maxey TD; Lenaghan RA; Novitzky J; Lindsey AT; Deuster PA
    Curr Sports Med Rep; 2019 May; 18(5):178-182. PubMed ID: 31082891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary supplement labeling and advertising claims: are clinical studies on the full product required?
    Villafranco JE; Bond K
    Food Drug Law J; 2009; 64(1):43-67. PubMed ID: 19998572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Legislative regulation of production and turnover of products for people with different diseases].
    Pritul'skaia NV; Motuzka IuN; Antiushko DL
    Vopr Pitan; 2013; 82(4):63-8. PubMed ID: 24340934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional foods: the Food and Drug Administration perspective.
    Ross S
    Am J Clin Nutr; 2000 Jun; 71(6 Suppl):1735S-8S; discussion 1739S-42S. PubMed ID: 10837331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Systematic Narrative Review of the Evidence for Labeling of Natural Health Products and Dietary Supplements.
    Boon H; Bozinovski N
    J Altern Complement Med; 2019 Aug; 25(8):777-788. PubMed ID: 31013437
    [No Abstract]   [Full Text] [Related]  

  • 13. A comprehensive strategy to overhaul FDA authority for misleading food labels.
    Pomeranz JL
    Am J Law Med; 2013; 39(4):617-47. PubMed ID: 24494445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
    NIH Consens State Sci Statements; 2006 May 15-17; 23(2):1-30. PubMed ID: 17332802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese newspaper advertisements for dietary supplements before and after COVID-19: a content analysis.
    Okuhara T; Yokota R; Shirabe R; Iye R; Okada H; Kiuchi T; Chiba T; Akamatsu R
    BMJ Open; 2021 Nov; 11(11):e050898. PubMed ID: 34815281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities to address the failure of online food retailers to ensure access to required food labelling information in the USA.
    Pomeranz JL; Cash SB; Springer M; Del Giudice IM; Mozaffarian D
    Public Health Nutr; 2022 Jan; 25(5):1-9. PubMed ID: 35067257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-Party Evaluation: A Review of Dietary Supplements Dispensed by Military Treatment Facilities From 2007 to 2011.
    Jones DR; Kasper KB; Deuster PA
    Mil Med; 2015 Jul; 180(7):737-41. PubMed ID: 26126242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of dietary supplements.
    Larsen LL; Berry JA
    J Am Acad Nurse Pract; 2003 Sep; 15(9):410-4. PubMed ID: 14560437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.